Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
Clinical trial NCT03946943 · UNKNOWN
Trial details
- NCT number
- NCT03946943
- Sponsor
- Di Wu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-19
- Primary completion
- 2022-07-19
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.